4.7 Article

Development and characterization of a Flow Focusing multi nebulization system for sample introduction in ICP-based spectrometric techniques

期刊

JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY
卷 24, 期 9, 页码 1213-1221

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/b821531f

关键词

-

向作者/读者索取更多资源

In this work, a new multiple nebulizer for liquid sample introduction in ICP-based spectrometers was developed and characterized on ICP-AES. The association of the Flow Focusing multiple nebulizer (FFMN) and a dedicated spray chamber was called Flow Focusing multi nebulization system (FFMNS). The nebulizer incorporates four nebulization nozzles with independent liquid feeding and a common gas inlet. Four different spray chambers were constructed and evaluated and the geometry of the best performing one was optimized. The FFNMS was characterized at 0.6-0.9 L min(-1) nebulizing gas flow and 0.04-0.6 mL min(-1) total liquid sample flow. Drop size and velocity distributions of primary and tertiary aerosols were studied together with total solvent and analyte transport rates. The system was characterized on ICP-AES in both axial and radial view modes and compared to a standard sample introduction system consisting in a concentric nebulizer and a cyclonyc spray chamber using model solutions and certified reference materials (CRM). In terms of sensitivity and LOD, the FFMNS showed a similar behavior to the reference system at half of the liquid sample uptake (0.5 mL min(-1) for FFMNS vs. 1 mL min(-1) for the standard system). The CRM ( hard drinking water) analysis recovery results are ranged between 89%-106% for FFMNS, and between 78%-102% for the reference system. Finally, the FFMNS was applied to an in chamber standard addition analysis of synthetic samples and CRM (estuarine water). The results of the CRM analysis showed better recoveries with respect to the external calibration for Cd, Mn and Ni, and similar results for Cu and Pb.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据